Criticalkare Pharma

Eltrog 25mg Tablet are an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).
This drug should not be used in individuals with known hypersensitivity or allergic reactions to the drug or its components. Allergic reactions can range from mild to severe and may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. Eltrog 25mg Tablet is contraindicated in patients with severe liver impairment or active liver disease. This drug can potentially cause hepatotoxicity, as indicated by increased liver enzymes and bilirubin levels. Using this drug in individuals with severe liver disease can further worsen liver function, so caution is advised. Your doctor will recommend that you are checked for cataracts. Your doctor should arrange regular testing if you do not have routine eye tests. You may also be checked for bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).

Uses
Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.Severe aplastic anemia.

Storage
Store Eltrog 25mg Tablet  at room temperature (25°C).

Side Effects
NauseaDiarrhea, abdominal painCommon coldCoughRespiratory tract infectionBack painHigh temperature, coughLoss of appetiteHair lossSwelling in feet or handsHeadache, dizzinessMouth and throat painJoint pain

Cresp 25mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.

Do not take Cresp 25mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding.

Uses
To treat anemia in chronic kidney failureTo treat anemia caused by chemotherapy

Storage
Store in a refrigerator (2°C to 8°C).Do not freeze. Store in the original package to protect from light.Keep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects
Swelling in the face and bodyLow blood pressureAbdominal painShortness of breathcoughHeart problemsSevere skin reactionsAnemiaSeizure attackLung problems

Cresp 40mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  
Do not take Cresp 40mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding. 

Uses
To treat anemia in chronic kidney failureTo treat anemia caused by chemotherapy

Storage
Store in a refrigerator (2°C to 8°C).Do not freeze. Store in the original package to protect from light.Keep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects
Swelling in the face and bodyLow blood pressureAbdominal painShortness of breathcoughHeart problemsSevere skin reactionsAnemiaSeizure attackLung problems

Cresp 100mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath.  
Do not take Cresp 100mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding. 

Uses
To treat anemia in chronic kidney failureTo treat anemia caused by chemotherapy

Storage
Store in a refrigerator (2°C to 8°C).Do not freeze. Store in the original package to protect from light.Keep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects
Swelling in the face and bodyLow blood pressureAbdominal painShortness of breathcoughHeart problemsSevere skin reactionsAnemiaSeizure attackLung problems

Anti D 300mcg Injection PFS contains active components called Anti-Rh(D) immunoglobulin . It is a medication used to prevent Rh(D) hemolytic disease of the newborn (HDN). This condition can occur when an Rh-negative mother carries an Rh-positive baby. It significantly reduces the risk of Rh-negative mothers developing antibodies against Rh(D) antigens, which could otherwise lead to HDN in subsequent pregnancies.
Individuals with a known severe allergy or hypersensitivity to any component of Anti D 300mcg Injection PFS should not receive the medication.  It should not be given to Rh-positive mothers as they already have Rh(D) antigens on their red blood cells and cannot develop Rh antibodies. If a woman is already sensitized to Rh(D) antigens (meaning she has developed Rh antibodies in a previous pregnancy or event), administering this medication will not reverse the sensitization. It is only effective as a preventive measure and should not be given in this situation.

Uses
Prevention of Rh SensitizationPrevention of Rh Hemolytic Disease of the Newborn (HDN)Preventing Alloimmunization

Storage
Stored at room temperature from 2-8°C.Keep away from moisture, heat, and light.It should not be frozen.

Side Effects
Allergic reactionsBlood Clots (thromboembolism)Kidney issuesInfectionsLocal reactionsLow-grade fever